Bank of New York Mellon’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-146,549
| Closed | -$542K | – | 4448 |
|
|
2017
Q4 | $542K | Buy |
146,549
+333
| +0.2% | +$1.23K | ﹤0.01% | 3579 |
|
|
2017
Q3 | $598K | Sell |
146,216
-8,359
| -5% | -$34.2K | ﹤0.01% | 3495 |
|
|
2017
Q2 | $574K | Buy |
154,575
+133,962
| +650% | +$497K | ﹤0.01% | 3541 |
|
|
2017
Q1 | $85K | Sell |
20,613
-7,788
| -27% | -$32.1K | ﹤0.01% | 4058 |
|
|
2016
Q4 | $122K | Buy |
28,401
+10,453
| +58% | +$44.9K | ﹤0.01% | 3990 |
|
|
2016
Q3 | $176K | Sell |
17,948
-2,648
| -13% | -$26K | ﹤0.01% | 3919 |
|
|
2016
Q2 | $116K | Sell |
20,596
-34,070
| -62% | -$192K | ﹤0.01% | 4024 |
|
|
2016
Q1 | $417K | Buy |
54,666
+400
| +0.7% | +$3.05K | ﹤0.01% | 3518 |
|
|
2015
Q4 | $722K | Sell |
54,266
-1,484
| -3% | -$19.7K | ﹤0.01% | 3347 |
|
|
2015
Q3 | $917K | Sell |
55,750
-12,620
| -18% | -$208K | ﹤0.01% | 3214 |
|
|
2015
Q2 | $1.53M | Buy |
68,370
+12,760
| +23% | +$286K | ﹤0.01% | 3084 |
|
|
2015
Q1 | $544K | Buy |
55,610
+3,108
| +6% | +$30.4K | ﹤0.01% | 3575 |
|
|
2014
Q4 | $598K | Buy |
52,502
+1,018
| +2% | +$11.6K | ﹤0.01% | 3541 |
|
|
2014
Q3 | $594K | Buy |
51,484
+1,611
| +3% | +$18.6K | ﹤0.01% | 3556 |
|
|
2014
Q2 | $970K | Buy |
49,873
+33,577
| +206% | +$653K | ﹤0.01% | 3329 |
|
|
2014
Q1 | $292K | Buy |
16,296
+2,844
| +21% | +$51K | ﹤0.01% | 3739 |
|
|
2013
Q4 | $142K | Hold |
13,452
| – | – | ﹤0.01% | 3894 |
|
|
2013
Q3 | $166K | Hold |
13,452
| – | – | ﹤0.01% | 3805 |
|
|
2013
Q2 | $127K | Buy |
+13,452
| New | +$127K | ﹤0.01% | 3854 |
|